Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Some costly cancer drugs can have unclear patient benefits
Cancer drugs are a dominant area in the pharmaceutical industry, constantly developing and launching new…
Metastatic prostate cancer characterised using mathematical modeling during treatment
In a new study published and included on the cover of the journal Cancer Research, Moffitt Cancer Center researchers…
Existing cancer drugs have potential to benefit thousands more patients
New research, published in Nature Genetics, shows that more people may benefit from PARP inhibitor drugs,…
Prime Minister’s science prizes awarded for algebra expertise, anti-cancer research and excellence in science teaching
Michael Hopkin, The Conversation and Noor Gillani, The Conversation The 2019 Prime Minister’s Prize for Science has been awarded to…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.